Volpara Health Technologies Ltd is a leading provider of breast imaging analytics and analysis products that improve clinical decision-making and the early detection of breast cancer.
Every day, Volpara software helps clinicians better understand their patients and administrators better understand their practices.
Volpara listed on the ASX in April 2016. It raised A$10 million: ramp up its management & sales force, expand product offerings and offer advanced data analytics.
The company had solid early sales. In FY16, its revenue was NZ$2.5 million (up 31% pcp) with a small sales team and capital sales model. Around 90% of sales are in the US.
